CYP1B1-IN-5

CAS No. 176442-56-1

CYP1B1-IN-5( —— )

Catalog No. M36491 CAS No. 176442-56-1

CYP1B1-IN-5 is a selective and potent cytochrome P450 1B1 (CYP1B1) inhibitor with an IC50 of 4.7 nM.CYP1B1-IN-5 can be used for the study of metabolism-related diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 459 In Stock
10MG 657 In Stock
25MG 1026 In Stock
50MG 1386 In Stock
100MG 1832 In Stock
200MG Get Quote In Stock
500MG 3655 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CYP1B1-IN-5
  • Note
    Research use only, not for human use.
  • Brief Description
    CYP1B1-IN-5 is a selective and potent cytochrome P450 1B1 (CYP1B1) inhibitor with an IC50 of 4.7 nM.CYP1B1-IN-5 can be used for the study of metabolism-related diseases.
  • Description
    CYP1B1-IN-5 (Compound 6q) is a potent and selective cytochrome P450 1B1 (CYP1B1) inhibitor with an IC50 of 4.7 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    P450
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    176442-56-1
  • Formula Weight
    349.12
  • Molecular Formula
    C14H8INO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1OC(=NC=2C1=CC=CC2)C3=CC=C(I)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yi L, et al. A new class of CYP1B1 inhibitors derived from bentranil. Bioorg Med Chem Lett. 2022 Dec 21;80:129112.?
molnova catalog
related products
  • TAK-700 (Orteronel)

    Orteronel(TAK-700) was selected as a candidate for clinical evaluation.

  • Guan-fu base A hydro...

    Guan-fu base A hydrochloride is an antiarrhythmic alkaloid was isolated from Aconitum coreanum. Guanfu base A is hydrochloride a CYP2D6 inhibitor of human, monkey, and dog isoforms.

  • Lofemizole

    Lofemizole is an antagonist of CYP1A2.